Characterization of Long Covid Pain in Primary Care
Determination and Characterization of Persistent Musculoskeletal Pain in Covid-19 Patients in Primary Care.
1 other identifier
observational
300
1 country
1
Brief Summary
Justification: among the sequelae of Covid-19 in clinical practice we frequently find persistent neuromusculoskeletal pain. Prevalence data and the underlying mechanisms of such pain are very limited in the scientific literature. Therefore, with this research we will try to answer these questions. Main objective: to determine and characterize persistent musculoskeletal pain in Covid-19 patients. Method: two phases. First, a descriptive cross-sectional study will be carried out to estimate the prevalence of Long Covid Pain (LCP). Second phase, a case-control study will be carried out using the sample obtained in the first phase as the population. The sample will be divided into two groups: post-Covid-19 patients with LCP and post-Covid-19 patients without persistent pain (control group). The two groups will be matched according to sex, age and level of severity of the pathology. An assessment and comparison between groups will be made of the following variables: central sensitization, healthy physical condition and blood test values, which will be evaluated by means of physical examination, questionnaires and laboratory tests. Applicability of the results: this is a pioneering project at the national level, which would determine more reliably the prevalence of LCP in postcovid and could be a first step in the search for the best therapeutic strategies for these patients. This would help to improve the quality of life of these patients and to better manage the social and healthcare resources used in their treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 15, 2022
CompletedFirst Submitted
Initial submission to the registry
June 6, 2023
CompletedFirst Posted
Study publicly available on registry
June 8, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2024
CompletedJune 8, 2023
June 1, 2023
1.5 years
June 6, 2023
June 7, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Quality of life (QoL)
EQ-5D questionnaire (Qualitave of Life 5 Dimension): The EQ-5D-3L is a brief multi-attribute health status measure composed of five questions with Likert response options (descriptive system) and a visual analogue scale (EQ-VAS). The descriptive system covers five dimensions of health (mobility, self-care, usual activities, pain/discomfort, and anxiety/depression) with three levels of severity in each dimension (no problems, some problems, and extreme problems).
1 day
Secondary Outcomes (4)
Pain Intensity
1 day
Areas of pain
1 day
Quantitative sensory tests
1 day
Handgrip Strength assessment
1 day
Study Arms (2)
Long Covid Pain Patients
Control Group, healthy people
Patients that had had Covid-19 but did not developed chronic pain or other chronic symptoms.
Interventions
It is a case-control study, cross-sectional, so there is no intervention possible.
Eligibility Criteria
Long Covid Pain Patients
You may qualify if:
- Patients who have had Covid-19, with a confirmatory PCR+ test or positive antigen test and recorded in their primary care medical record.
- Subjects between 18-70 years old.
- Musculoskeletal pain of more than 12 weeks of evolution since the beginning of the infection.
- Agree to participate in the study and sign the informed consent form.
You may not qualify if:
- History of chronic musculoskeletal pain of more than 12 weeks of evolution prior to Covid-19.
- History of diagnosed major depression.
- Having a diagnosis of fibromyalgia prior to Covid-19 infection.
- Pregnancy.
- Pain of oncologic origin.
- Fracture or surgical intervention on the spine in the last year.
- Bladder or bowel incontinence.
- Saddle anesthesia.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Universidad de Valladolid
Valladolid, 47005, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 1 Day
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Phd Candidate
Study Record Dates
First Submitted
June 6, 2023
First Posted
June 8, 2023
Study Start
May 15, 2022
Primary Completion
December 1, 2023
Study Completion
February 1, 2024
Last Updated
June 8, 2023
Record last verified: 2023-06